FI110668B - Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn - Google Patents

Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn Download PDF

Info

Publication number
FI110668B
FI110668B FI20001460A FI20001460A FI110668B FI 110668 B FI110668 B FI 110668B FI 20001460 A FI20001460 A FI 20001460A FI 20001460 A FI20001460 A FI 20001460A FI 110668 B FI110668 B FI 110668B
Authority
FI
Finland
Prior art keywords
atopic
months
children
use according
probiotic
Prior art date
Application number
FI20001460A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20001460A0 (fi
FI20001460A (fi
Inventor
Erika Isolauri
Seppo Salminen
Original Assignee
Aboatech Ab Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8558595&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI110668(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aboatech Ab Oy filed Critical Aboatech Ab Oy
Priority to FI20001460A priority Critical patent/FI110668B/fi
Publication of FI20001460A0 publication Critical patent/FI20001460A0/fi
Priority to AU72572/01A priority patent/AU784921B2/en
Priority to US10/311,706 priority patent/US7112322B2/en
Priority to DE01951716T priority patent/DE01951716T1/de
Priority to EP09164284.3A priority patent/EP2201955B1/en
Priority to ES01951716T priority patent/ES2329549T3/es
Priority to DE60139554T priority patent/DE60139554D1/de
Priority to PT91642843T priority patent/PT2201955T/pt
Priority to EP09164285.0A priority patent/EP2206507B1/en
Priority to AT01951716T priority patent/ATE439138T1/de
Priority to ES09164284T priority patent/ES2754797T3/es
Priority to ES09164285T priority patent/ES2721848T3/es
Priority to PCT/FI2001/000588 priority patent/WO2001097822A1/en
Priority to PT01951716T priority patent/PT1296694E/pt
Priority to EP01951716A priority patent/EP1296694B1/en
Publication of FI20001460A publication Critical patent/FI20001460A/fi
Publication of FI110668B publication Critical patent/FI110668B/fi
Application granted granted Critical
Priority to US11/225,204 priority patent/US7988960B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20001460A 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn FI110668B (fi)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FI20001460A FI110668B (fi) 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
EP01951716A EP1296694B1 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases
PT91642843T PT2201955T (pt) 2000-06-20 2001-06-20 Bifidobacterium lactis bb-12 na prevenção primária de doenças atópicas
ES09164284T ES2754797T3 (es) 2000-06-20 2001-06-20 Bifidobacterium lactis Bb-12 en prevención primaria de enfermedades atópicas
DE01951716T DE01951716T1 (de) 2000-06-20 2001-06-20 Probiotika zur primären prävention atopischer erkrankungen
EP09164284.3A EP2201955B1 (en) 2000-06-20 2001-06-20 Bifidobacterium lactis Bb-12 in primary prevention of atopic diseases
ES01951716T ES2329549T3 (es) 2000-06-20 2001-06-20 Probioticos para la prevencion primaria de enfermedades atopicas.
DE60139554T DE60139554D1 (de) 2000-06-20 2001-06-20 Probiotika zur primären prävention atopischer erkrankungen
AU72572/01A AU784921B2 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases
EP09164285.0A EP2206507B1 (en) 2000-06-20 2001-06-20 Probiotics for use in primary prevention of atopic diseases
AT01951716T ATE439138T1 (de) 2000-06-20 2001-06-20 Probiotika zur primären prävention atopischer erkrankungen
US10/311,706 US7112322B2 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases
ES09164285T ES2721848T3 (es) 2000-06-20 2001-06-20 Probióticos para su uso en la prevención primaria de enfermedades atópicas
PCT/FI2001/000588 WO2001097822A1 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases
PT01951716T PT1296694E (pt) 2000-06-20 2001-06-20 Probióticos na prevenção primária de doenças atópicas
US11/225,204 US7988960B2 (en) 2000-06-20 2005-09-14 Probiotics in primary prevention of atopic diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20001460A FI110668B (fi) 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
FI20001460 2000-06-20

Publications (3)

Publication Number Publication Date
FI20001460A0 FI20001460A0 (fi) 2000-06-20
FI20001460A FI20001460A (fi) 2001-12-21
FI110668B true FI110668B (fi) 2003-03-14

Family

ID=8558595

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20001460A FI110668B (fi) 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn

Country Status (9)

Country Link
US (2) US7112322B2 (pt)
EP (3) EP2206507B1 (pt)
AT (1) ATE439138T1 (pt)
AU (1) AU784921B2 (pt)
DE (2) DE60139554D1 (pt)
ES (3) ES2754797T3 (pt)
FI (1) FI110668B (pt)
PT (2) PT1296694E (pt)
WO (1) WO2001097822A1 (pt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
RU2407784C2 (ru) 2003-12-17 2010-12-27 Н.В. Нютрисиа Пробиотический штамм lactobacillus casei, продуцирующий молочную кислоту, применение штамма для приготовления питательной композиции для лечения или профилактики легочной дисфункции, питательная композиция и способ ее получения, лекарственное средство для лечения или профилактики хронической обструктивной болезни легких у субъекта и применение штамма для приготовления лекарственного средства, контейнер
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1731137A1 (fr) * 2005-06-08 2006-12-13 Nestec S.A. Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles
EP1642570A1 (fr) 2004-10-04 2006-04-05 L'oreal Composition cosmétique et/ou dermatologique pour peaux sensibles
JP5112069B2 (ja) * 2004-10-04 2013-01-09 ロレアル 敏感肌のための化粧品及び／または皮膚科組成物
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
RU2270248C1 (ru) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US8021883B2 (en) 2005-05-11 2011-09-20 Chr. Hansen A/S Antibiotic-sensitive lactic acid bacteria strains
JP2009067679A (ja) * 2005-12-27 2009-04-02 Univ Of Tokushima 抗ヒスタミン作用を有する医薬
CA2645472C (en) 2006-03-10 2015-09-15 N.V. Nutricia Use of non-digestable saccharides for giving an infant the best start after birth
US8226936B2 (en) 2006-11-15 2012-07-24 Chr-Hansen A/S Tetracycline-sensitive bifidobacteria strains
EP2091340A1 (en) 2006-12-11 2009-08-26 Danisco A/S Composition
WO2008101450A1 (de) * 2007-02-22 2008-08-28 Schrezenmeir Juergen Probiotische, gram-positive bakterien zur prophylaxe, unterdrückung oder eliminierung von allergischen reaktionen bei menschen
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
US20090007924A1 (en) * 2007-04-30 2009-01-08 Iliff Edwin C Arbiter system and method of computerized medical diagnosis and advice
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
PT2668854E (pt) 2008-03-28 2015-10-22 Nestec Sa Probióticos para utilização em fêmeas de mamíferos gestantes para reforçar a imunidade da sua descendência
US20110053889A1 (en) * 2008-09-02 2011-03-03 Joanne Szabo Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
JP2013507394A (ja) * 2009-10-09 2013-03-04 プロセラ インコーポレイテッド 自閉症スペクトル障害と診断されたヒトにおいて自閉症スペクトル障害に関連する少なくとも一つの症状を低減するための、ペディオコッカス属を含む組成物及び方法
CN102269858A (zh) 2010-06-02 2011-12-07 北京智朗芯光科技有限公司 自动聚焦系统和自动聚焦方法
BR112012032994B1 (pt) * 2010-06-30 2018-11-21 Nestec S.A. usos cosméticos de ácido caftárico
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2510932A1 (en) 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
EP3366143A1 (en) 2011-06-20 2018-08-29 H.J. Heinz Company Brands LLC Probiotic compositions and methods
WO2013016111A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX368124B (es) 2011-08-29 2019-09-19 Abbott Lab Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
EP2617296A1 (en) 2012-01-19 2013-07-24 Nestec S.A. A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
EP2836224A4 (en) 2012-02-29 2015-12-16 Ethicon Endo Surgery Inc COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
DK2861242T3 (en) 2012-06-18 2018-10-29 Heinz Co Brands H J Llc GLUTEN RELATED DISORDERS
US9925223B2 (en) 2012-09-25 2018-03-27 Regents Of The University Of Minnesota Methods for making and using antimicrobial peptides
DK2994150T3 (da) 2013-05-10 2019-06-11 Heinz Co Brands H J Llc Probiotika og fremgangsmåde til anvendelse
US20150064304A1 (en) * 2013-09-03 2015-03-05 Mario Medri Probiotic lozenge, method of making same, and uses thereof
AU2014350419B2 (en) * 2013-11-15 2019-10-24 Société des Produits Nestlé S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
WO2015090349A1 (en) 2013-12-16 2015-06-25 Nestec S.A. Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants
EP2886660A1 (en) * 2013-12-20 2015-06-24 Rigas Tehniska universitate A fluorescent in situ hybridization method for identification of a microorganism
GB2551642B (en) 2014-10-31 2020-09-23 Pendulum Therapeutics Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
WO2016149687A1 (en) * 2015-03-18 2016-09-22 Whole Biome, Inc. Methods and compositions relating to microbial treatment and diagnosis of skin disorders
CA2950839C (en) * 2016-01-30 2023-09-12 Cooper Technologies Company Equipment rack and components thereof
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN113660941A (zh) * 2018-12-21 2021-11-16 雀巢产品有限公司 用于治疗变态反应性疾病的益生菌组合
WO2021138599A1 (en) * 2020-01-03 2021-07-08 Forte Subsidiary, Inc. Cosmetic compositions
CA3202748A1 (en) * 2020-11-24 2022-06-02 Johnson & Johnson Consumer Inc. Methods of preventing, delaying or ameliorating atopic diseases
WO2024042229A1 (en) 2022-08-25 2024-02-29 Chr. Hansen A/S Bifidobacterium strains with improved stability

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
US5246591A (en) * 1990-07-13 1993-09-21 Pact, Incorporated Separation of metal ions on an anion exchange resin by chromatographic elution
BE1009359A7 (fr) 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
GB9808579D0 (en) * 1998-04-22 1998-06-24 Novartis Nutrition Ag Improvements in or relating to organic compounds
JP4010062B2 (ja) * 1998-09-02 2007-11-21 医療法人社団青藍会 アトピー性皮膚炎を防ぐ保健食品
JP2000086524A (ja) * 1998-09-05 2000-03-28 Shadan Seirankai 生きた腸内細菌を含有する抗アレルギー剤
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases

Also Published As

Publication number Publication date
WO2001097822A1 (en) 2001-12-27
EP1296694B1 (en) 2009-08-12
ES2754797T3 (es) 2020-04-20
AU784921B2 (en) 2006-07-27
EP2201955B1 (en) 2019-08-14
EP1296694A1 (en) 2003-04-02
US20030180272A1 (en) 2003-09-25
US7112322B2 (en) 2006-09-26
ES2329549T3 (es) 2009-11-27
AU7257201A (en) 2002-01-02
FI20001460A0 (fi) 2000-06-20
DE60139554D1 (de) 2009-09-24
PT2201955T (pt) 2019-11-25
PT1296694E (pt) 2009-10-28
FI20001460A (fi) 2001-12-21
US7988960B2 (en) 2011-08-02
EP2201955A1 (en) 2010-06-30
EP2206507A1 (en) 2010-07-14
DE01951716T1 (de) 2005-06-23
US20060013806A1 (en) 2006-01-19
EP2206507B1 (en) 2019-03-13
ATE439138T1 (de) 2009-08-15
ES2721848T3 (es) 2019-08-05

Similar Documents

Publication Publication Date Title
FI110668B (fi) Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
Dzidic et al. Oral microbiota maturation during the first 7 years of life in relation to allergy development
JP5117171B2 (ja) 抗アレルギーの乳酸菌
Pedrosa et al. Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects
Kalliomäki et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing
Duffy et al. Modulation of rotavirus enteritis during breast-feeding: implications on alterations in the intestinal bacterial flora
US9707258B2 (en) Bioconversion of milk with Bifidobacterium breve for treatment of allergic manifestions in infants
BG107299A (bg) Употреба на lactobacillus casei в имуностимулиращи пептиди
JP6985342B2 (ja) ビフィドバクテリウム ラクティス ｇｋｋ２、それを含む組成物、およびアレルギー性喘息改善のためのその使用
JP2020523329A (ja) バチルス・コアグランスの脂質低下効果
JP2023037613A (ja) 乳酸菌含有組成物
US11723936B2 (en) Therapeutic uses of Lactobacillus plantarum
CN101503662B (zh) 用于抗过敏症状的微生物株、其组合物和以此微生物株刺激细胞产生干扰素-γ的方法
Yamashita et al. Intake safety of Lactobacillus helveticus SBT2171 and its effects on nasal and ocular symptoms associated with mites and house dust: an open-label study and a randomized, double-blind, placebo-controlled, parallel group study.
CN111617061A (zh) 一种亚精胺在制备提高毛螺菌属细菌丰度制剂中的应用
Mosaddek Effect of probiotics in the treatment of acute watery diarrhoea in children admitted to a tertiary care hospital in Bangladesh: a non-randomized prospective clinical trial
Özdemir et al. Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings
WO2021059241A1 (en) Microbiome compositions and methods of treatment of atopic diseases
CN114990004B (zh) 一种分泌型免疫球蛋白a包裹态罗伊氏乳杆菌及防治妊娠糖尿病的应用
Chundakkattumalayil et al. Health endorsing potential of Lactobacillus plantarum MBTU-HK1 and MBTU-HT of Honey bee gut origin
McDade et al. Fetal Programming of Immune Function
Çalışır et al. Evaluation of the effect of probiotics on celiac patients
Mosaddek et al. Effect of Probiotics in Acute Watery Diarrhea in Children Admitted To a Bangladeshi Tertiary-Care Hospital: A Non-Randomized Prospective Clinical Trial
Elebeedy et al. The Healing Effect of Probiotics on Indomethacin Induced Gastric Ulcer in Rats
Shabaan et al. Study of Different Types of Gut Flora among Obese Egyptian Children

Legal Events

Date Code Title Description
RF Appeal filed
PC Transfer of assignment of patent

Owner name: NESTEC S.A.

Free format text: NESTEC S.A.

FCK Appeal rejected